Pneumonia Testing Industry Landscape 2023-2030: U.S. and China Leading the Way
July 27, 2023 07:18 ET
|
Research and Markets
Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "Pneumonia Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market analysis for...
Mycoplasma Testing Global Market to 2030: Rising Cell Culture Contamination Drives Growth
July 06, 2023 06:48 ET
|
Research and Markets
Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kits & Reagents), By Technology (PCR, ELISA, Direct Assay,...
$43.1 Billion Point-of-Care Diagnostics Markets by Platform, Application, Sample Type, and End User - Global Forecast to 2030
June 01, 2023 09:23 ET
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood...
Global Legionella Testing Market Analysis & Epidemiology Report, 2016-2022 & 2023-2031
May 26, 2023 07:53 ET
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Global Legionella Testing Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global legionella...
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
May 15, 2023 16:15 ET
|
OpGen, Inc.
Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022Expanded U.S. growth opportunities with the Unyvero...
Global Infection Surveillance Solutions Market 2023 - 2030: Increasing Adoption of Inorganic Growth Strategies Fuels the Sector
April 19, 2023 10:33 ET
|
Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User (Hospitals, Clinics, Ambulatory Surgical Center,...
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
April 18, 2023 16:30 ET
|
OpGen, Inc.
Fisher Healthcare, a part of Thermo Fisher Scientific, will become the non-exclusive national laboratory distribution partner alongside OpGen, Inc.’s direct sales in the U.S. for the Unyvero A50...
Global Hospital Acquired Disease Testing Market Report 2022-2030: Top Winning Strategies, Top Investment Markets, Emerging Trends, Technological Analysis, & Case Studies
December 14, 2022 07:13 ET
|
Research and Markets
Dublin, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The "Hospital Acquired Disease Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress West Coast 2022
December 01, 2022 08:30 ET
|
Blue Water Vaccines Inc.
CINCINNATI, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), today announced that Ali Fattom, Ph.D., will present at the World Vaccine...
Global Mycoplasma Testing Market Report 2022 to 2030: Increasing Need for Mycoplasma Quality Control for Cell Substrates and Biopharmaceuticals Presents Opportunities
November 15, 2022 07:58 ET
|
Research and Markets
Dublin, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The "Mycoplasma Testing Market Size, Share & Trends Analysis by Product (Instruments, Kit & Reagents), by Technology (PCR, ELISA), by Application...